Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.43 |
| ▸ | LSS | P48449 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296280 | 0.85 | ALDH1A1 (0.55) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| Iodide SCHEMBL31186398 | 0.83 | ALDH1A1 (0.53) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| SCHEMBL2092499 | 0.80 | KIF11 (0.57) | ALDH1A1TAAR1MAOB | |
| SCHEMBL1436108 | 0.76 | PTPN1 (0.54) | ALDH1A1TAAR1KCNH2TMEM97IDO1 | |
| SCHEMBL25588013 | 0.74 | ALDH1A1 (0.52) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| SCHEMBL27982876 | 0.74 | ALDH1A1 (0.52) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| Hydrochloric Acid SCHEMBL7347655 | 0.74 | IDO1 (0.52) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| SCHEMBL12233642 | 0.73 | ALDH1A1 (0.51) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| SCHEMBL3964858 | 0.73 | ALDH1A1 (0.51) | ALDH1A1TAAR1KCNH2TMEM97LSS | |
| SCHEMBL15129318 | 0.72 | ALDH1A1 (0.50) | ALDH1A1TAAR1KCNH2TMEM97LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685727-B2 | Compounds active towards nuclear receptors | NUEVOLUTION A/S (DK) | 2023-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685727-B2 | Compounds active towards nuclear receptors | NCOA1, NR1H2, NCOA3 | ALDH1A1 1638/4885TAAR1 1091/4885KCNH2 4790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.